Columbia Labs Slams Investor Suit Over Rejected Drug
Columbia Laboratories Inc. fired back Friday in New Jersey federal court against consolidated investor claims that the company and its executives inflated its stock by talking up its premature-birth-preventing drug Prochieve...To view the full article, register now.
Already a subscriber? Click here to view full article